EL SEGUNDO, Calif. -- Computer Sciences Corporation (CSC) announced that DVC LLC, a CSC company, has been awarded approximately $19.7 million in grants and contract modifications from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health.
The new grants and contract modifications are in addition to the award of an $11 million grant to CSC from the NIAID in September 2003.
Under the terms of these new awards, DVC will continue the advanced development of vaccines for tularemia, botulism and Venezuelan equine encephalitis. The company will perform stability testing and manufacture a current good manufacturing practices pilot batch of live tularemia vaccine. DVC also will conduct a phase 2 clinical trial for its Venezuelan equine encephalitis vaccine candidate and continue development of a stable multivalent botulinum vaccine candidate.
NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID conducts and supports research that strives to understand, treat and ultimately prevent the myriad of infectious, immunologic and allergic diseases that threaten hundreds of millions of people worldwide.
DVC is a biopharmaceutical company dedicated to the development and licensure of safe and efficacious biodefense vaccines and therapeutics. DVC is part of CSCs Enforcement, Security and Intelligence organization, which CSC created in 2002 to support programs enhancing U.S. security.
Source: Computer Sciences Corporation
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.